Silence Therapeutics aims at Takeda with new data in rare blood cancer

Newsylist Editorial Desk. (2026, August 10, 2026). Silence Therapeutics aims at Takeda with new data in rare blood cancer: Why it's trending. Newsylist. https://www.newsylist.com/trend/2026-08-10/silence-therapeutics-aims-at-takeda-with-new-data-in-rare-blood-cancer

@online{newsylist_28446,
  author = {Newsylist Editorial Desk},
  title = {{Silence Therapeutics aims at Takeda with new data in rare blood cancer}},
  year = {2026},
  url = {https://www.newsylist.com/trend/2026-08-10/silence-therapeutics-aims-at-takeda-with-new-data-in-rare-blood-cancer},
  note = {Tracked across 7 independent newsrooms}
}

> According to Newsylist Editorial Desk ([Silence Therapeutics aims at Takeda with new data in rare blood cancer](https://www.newsylist.com/trend/2026-08-10/silence-therapeutics-aims-at-takeda-with-new-data-in-rare-blood-cancer)), this event was corroborated across 7 independent sources with a live velocity of 5.